GABA Probiotic, LP815®

LP815 is a clinically studied probiotic that produces GABA in the gut for sustained gut-brain support

GABA-Producing Probiotic for Stress, Mood, and Sleep Support

GABA-Producing Probiotic for Gut-Brain Support

GABA (Gamma-Aminobutyric Acid) is a key inhibitory neurotransmitter that helps regulate the nervous system by slowing excessive neural activity.¹ This calming effect plays a critical role in supporting mood, stress response, and sleep quality.² When GABA levels are low or imbalanced, it can contribute to heightened stress, irritability, and disrupted sleep.³⁻⁵

However, traditional GABA supplements often provide only short-lived effects due to limited bioavailability. LP815 is designed to overcome this limitation by enabling sustained, gut-mediated production of GABA, delivering consistent support for mood, stress, and sleep throughout the day and night.

How does LP815 work?

GABA produced in the gut can influence brain function and mood through the gut-brain axis, a bidirectional communication pathway between the gut and central nervous system. LP815  is an orally delivered GABA-producing probiotic that works with the existing gut microbiome to continuously generate GABA.

Image of the gut-brain feedback loop. Neuromodulators, Dysbiosis and Bidirectional signaling.

What is a GABA-producing probiotic?

A GABA-producing probiotic is a functional microbial strain designed to generate gamma-aminobutyric acid (GABA) directly in the gut, enabling microbiome-driven support of the gut-brain axis.

LP815 is differentiated by its ability to provide prolonged, sustained GABA production rather than a short-lived dose. By working with the existing gut microbiota, LP815 continuously generates GABA over time, offering a consistent approach to supporting stress, mood, and sleep.

What are the benefts of GABA Probiotic, LP815?2,5, 7-9

Helps reduce feelings of irritability

Promotes a calm mood

Supports a healthy stress management

Supports deep restorative sleep

Helps reduce nighttime sweating

LP815 Clinical Substantiation

Explore the clinical publications that validate the science behind Verb Biotics’ LP815 solution. Our research demonstrates a clean commitment to proven efficacy, measurable outcomes, and a new standard of rigor in microbiome innovation.

Clinical Trial Overviews
Study #1 | Stress & Mood | Beneficial Microbes

Overview: This study assessed the impact of Lactiplantibacillus plantarum LP815 on stress.

Study Design: Randomized, double-blind, placebo-controlled, wearable-device clinical trial in 83 healthy adults with mild to moderate anxiety. The study was conducted over a 7-week period with one week of baseline data followed by 5 billion CFU of LP815 or placebo use for 6 weeks.

Outcomes: 5 billion CFU of LP815 significantly reduced stress in a diverse cohort of adults at 4 weeks and 6 weeks following daily consumption.

Published in Beneficial Microbes, 2025

Read the Study

Study #2 | Sleep | Nature Scientific Reports

Overview: This study evaluated whether Lactiplantibacillus plantarum LP815 could improve sleep quality and elevate GABA levels.

Study Design: Randomized, double-blind, placebo-controlled, wearable-device clinical trial with 139 enrolled healthy adults with at least moderate difficulty falling asleep. Participants were assigned to either a placebo or 5 billion CFU of LP815 daily for 6 weeks. A small sub-cohort provided urinary samples for neurotransmitter analysis, including GABA. 

Outcomes: Participants taking 5 billion CFU of LP815 experienced significant improvement in sleep quality, with 77% achieving a clinically meaningful 4-point reduction compared to 58% on placebo. Time asleep as well as deep sleep duration was significantly greater in the LP815 cohort. A sub-study shows that LP815 may increase systematic GABA levels within the first week. 

Read the Study

From Labs to Lives: Clinical Results

Reduced Stress

Participants receiving 5 billion CFU of LP815 exhibited significantly lower GAD-7 scores at weeks 4 and 6 compared to placebo (p<0.05). 68% of participants’ GAD-7 total score improved at week 6 in the 5 billion CFU cohort, as compared to just 26% of the placebo cohort.

Those taking LP815 reduced their stress by 6.68 points, compared to 4.42 in the placebo group, reflecting a 151% greater improvement.

 

Improved Sleep Quality

Participants who received LP815 at the 5 billion CFU dosage exhibited significantly lower insomnia index scores at 6 weeks compared to the placebo group (p=0.02). 77.3% of participants in the LP815 cohort exhibited improvement by 4+ points at week 6.

LP815 also significantly increased sleep duration metrics (measured through the Oura Ring), showing that time in bed, total sleep, and deep sleep were significantly longer in the LP815 group compared to placebo (p<0.05). 

 

Increased Urinary GABA Levels

Subjects who received LP815 exhibited an increase in urinary GABA compared to the placebo group during the first week of use (p<0.05) which was associated with improved sleep and reduced stress.

GABA levels increased rapidly after the first week, and were relatively stable through week 6 (p=0.04), highlighting the ability of LP815 to create a GABA factory in the gut, resulting in sustained GABA levels. 

Dive Deeper into the Science. Download our LP815 Clinical Substantiation Report.

How does LP815 work?

GABA factory

The ability of LP815 to produce GABA itself can be thought of as enabling a GABA factory in the gut. This localized, sustained production supports more consistent modulation of mood, stress response, and nervous system signaling

GI performance

LP815 is derived from a natural Lactiplantibacillus plantarum strain that survives the harsh conditions of the gut to produce GABA.

Prolonged release

Unlike traditional GABA supplements which deliver a bolus dose of GABA resulting in an immediate but transient spike of GABA levels that is gone in a few hours, LP815 offers a consistent and prolonged time release of GABA, and has been studied and evaluated for its ability to provide extended and consistent stress, irritability, and sleep modulation throughout the day and night.

Lower dosage for greater application flexibility

LP815, at a dose of 5 billion CFU, produces 50mg of GABA which is the dose associated with stress, irritability, and sleep benefits.2-5, 7-9 This low CFU dose enables flexibility when formulating.

Applications

Add in mood, stress, sleep, and relaxation dietary supplements. Stack with other function-specific biotics for a robust symbiotic offering.

 

STRESS & MOOD | SLEEP QUALITY | GUT-BRAIN AXIS | CALMING & RELAXATION

 GRAS  |  Allergen-free | Non-GMO 

GABA Probiotic, LP815 Frequently Asked Questions

What makes LP815 unique?

LP815 is function-first, not CFU-first. Most probiotics focus on colony-forming units and colonization. LP815 is designed to produce GABA, a bioactive that supports the gut-brain axis, delivering consistent, measurable effects instead of variable bacterial counts.

What makes LP815 a 'GABA-producing' probiotic?

LP815 works with existing microbes in the gut to create more GABA, acting as a “GABA factory,” delivering steady GABA to support calm mood, stress resilience, and sleep—unlike quick-spike supplements.

How does LP815 support sleep?

LP815 supports sleep by sustaining GABA levels from day to night. GABA regulates the body’s relaxation response and signals readiness for rest. By maintaining steady GABA via the gut-brain axis, LP815 promotes deeper relaxation and more consistent sleep quality over time, not just short-term effects.

Why does the body need GABA—and how does LP815 help?

Your body relies on steady GABA signaling to maintain calm, stress resilience, and balanced mood. LP815 is a GABA-producing probiotic designed to support this pathway from the gut. By helping maintain consistent GABA availability via the gut-brain axis, LP815 provides dual-action stress and sleep support.

Is LP815 clinically studied?

Yes! LP815 is supported by real-world research and peer-reviewed data on stress, mood, and sleep outcomes. LP815 is GRAS, non-GMO, and allergen-free, meeting the highest standards of safety and quality. Made in the U.S., LP815 is suitable for use in a variety of dietary supplements. Read the study in full here.

Interested in learning more 
about GABA Probiotic, LP815?

Sources

 

  1. Jewett BE, Sharma S. Physiology, GABA. StatPearls. 2023.
  2. Hepsomali P, Groeger JA, Nishihira J, Scholey A. Effects of Oral Gamma-Aminobutyric Acid (GABA) Administration on Stress and Sleep in Humans: A Systematic Review. Front Neurosci 2020;14:923. https://doi.org/10.3389/fnins.2020.00923.
  3. Yamatsu A, Yamashita Y, Pandharipande T, Maru I, Kim M. Effect of oral γ-aminobutyric acid (GABA) administration on sleep and its absorption in humans. Food science and biotechnology. 2016;25(2):547-551.
  4. Yamatsu A, Yamashita Y, Maru I, Yang J, Tatsuzaki J, Kim M. The Improvement of Sleep by Oral Intake of GABA and Apocynum venetum Leaf Extract. Journal of nutritional science and vitaminology. 2015;61(2):182-187.
  5. Yoto A, Murao S, Motoki M, et al. Oral intake of γ-aminobutyric acid affects mood and activities of central nervous system during stressed condition induced by mental tasks. Amino acids. 2012;43(3):1331-1337.
  6. Grant, A.D., Erfe, M.C.B., Delebecque, C.J., Keller, D., Zimmerman, N.P., Oliver, P.L., Youssef, B., Moos, J., Luna, V., & Craft, N. (2025). Lactiplantibacillus plantarum Lp815 decreases anxiety in people with mild to moderate anxiety: a direct-to-consumer, randomised, double-blind, placebo-controlled study. Beneficial Microbes, 16(5), 521-532.
  7. Stress in America 2023; a nationwide survey conducted by The Harris Poll on behalf of America Psychological Association among more than 3,000 U.S. adults age 18+. LINK
  8. Abdou AM, Higashiguchi S, Horie K, Kim M, Hatta H, Yokogoshi H. Relaxation and immunity enhancement effects of gamma-aminobutyric acid (GABA) administration in humans. Biofactors. 2006;26(3):201-8.doi:10.1002/biof.5520260305
  9. Grant, A.D., Erfe, M.C.B., Delebecque, C.J. et al. Lactiplantibacillus plantarum Lp815 improves sleep and increases urinary GABA in a randomized, double-blind, placebo-controlled study of sleep disturbance. Sci Rep 16, 644 (2026).

Disclaimer
This material is provided solely for business-to-business use by qualified industry professionals. It is not designed for consumer-facing communication or distribution.